ClinVar Miner

Submissions for variant NM_001042492.3(NF1):c.2032_2034delinsTCA (p.Pro678Ser)

dbSNP: rs1597712318
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Ambry Genetics RCV002319200 SCV001174823 uncertain significance Hereditary cancer-predisposing syndrome; Cardiovascular phenotype 2022-03-14 criteria provided, single submitter clinical testing The c.2032_2034delCCGinsTCA variant (also known as p.P678S), located in coding exon 18 of the NF1 gene, results from an in-frame deletion of CCG and insertion of TCA at nucleotide positions 2032 to 2034. This results in the substitution of the proline residue for a serine residue at codon 678, an amino acid with similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be neutral by in silico analysis (Choi Y et al. PLoS ONE. 2012; 7(10):e46688). Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.